Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines

Allergol Int. 2023 Apr;72(2):332-334. doi: 10.1016/j.alit.2022.10.001. Epub 2022 Oct 22.

Authors

Florian Stehlin¹, Francesco Tommasini¹, Véronique Monzambani-Banderet¹, Cedric Girard², Daniel Yerly³, Camillo Ribi¹, Yannick D Muller⁴

Affiliations

¹ Division of Immunology and Allergy, University Hospital of Lausanne, Lausanne, Switzerland.
² Pharmacy, University Hospital of Lausanne, Hospital and University of Lausanne, Lausanne, Switzerland.
³ Adverse Drug Reactions - Analysis & Consulting (ADR-AC) GmbH, Bern, Switzerland.
⁴ Division of Immunology and Allergy, University Hospital of Lausanne, Lausanne, Switzerland. Electronic address: Yannick.muller@chuv.ch.

No abstract available

Publication types

Letter

MeSH terms

Adult
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
Immunization
SARS-CoV-2
Vaccination / adverse effects

Substances

COVID-19 Vaccines